Literature DB >> 8318694

Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation.

L W Chung1.   

Abstract

Prostate cancer is the most common malignancy and the second leading cause of cancer death in American men. One of the most intriguing aspects of prostate cancer is that despite the similar high incidence of latent forms of prostate cancer detected in men throughout the world, remarkable disparity exists in the rate of clinical progression of this disease. Men living in North America have significant disease progression, whereas men living in Japan or China do not. In this article, the potential epigenetic factors that may play a critical role in determining the rate of prostate cancer growth and progression is discussed. We propose that stromal-epithelial interaction may be of fundamental importance to prostate cancer growth and expression of its invasive phenotypes. Furthermore, we have demonstrated that delivering appropriate growth factor(s) and/or extracellular matrice(s) to an established non-tumorigenic prostatic epithelial cell line (but not normal prostatic epithelial cells) may accelerate disease progression and may irreversibly affect prostatic epithelial cell behavior.

Entities:  

Mesh:

Year:  1993        PMID: 8318694

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal.

Authors:  Jian-Hua Guo; Juan Zhou; Yang Zhao; Peng-Yue Liu; Hai-Jun Yao; Jun Da; Ming Zhang; Zhe Zhou; Qi Chen; Yu-Bing Peng; Zhong Wang
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 3.  Spinal cord compression in prostate cancer.

Authors:  J L Osborn; R H Getzenberg; D L Trump
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.

Authors:  Katsumi Shigemura; Shuji Isotani; Ruoxiang Wang; Masato Fujisawa; Akinobu Gotoh; Fray F Marshall; Haiyen E Zhau; Leland W K Chung
Journal:  Prostate       Date:  2009-06-15       Impact factor: 4.104

Review 5.  Regulation of prostate growth by fibroblast growth factors.

Authors:  M T Story
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

6.  A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells.

Authors:  Nanyue Chen; Xiang-Cang Ye; Khoi Chu; Nora M Navone; E Helene Sage; Li-Yuan Yu-Lee; Christopher J Logothetis; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

7.  Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.

Authors:  P A Humphrey; X Zhu; R Zarnegar; P E Swanson; T L Ratliff; R T Vollmer; M L Day
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

8.  Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells.

Authors:  Chien-Jui Cheng; Xiang-cang Ye; Funda Vakar-Lopez; Jeri Kim; Shi-Ming Tu; Dung-Tsa Chen; Nora M Navone; Li-Yuan Yu-Lee; Sue-Hwa Lin; Mickey C-T Hu
Journal:  Mol Cancer Res       Date:  2007-07       Impact factor: 5.852

9.  TNFα modulates Fibroblast Growth Factor Receptor 2 gene expression through the pRB/E2F1 pathway: identification of a non-canonical E2F binding motif.

Authors:  Sirio D'Amici; Simona Ceccarelli; Enrica Vescarelli; Ferdinando Romano; Luigi Frati; Cinzia Marchese; Antonio Angeloni
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression.

Authors:  Ruoxiang Wang; Xiaojuan Sun; Christopher Y Wang; Peizhen Hu; Chia-Yi Chu; Shurong Liu; Haiyen E Zhau; Leland W K Chung
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.